Gravitas Education ADR Cl. A Aktie

Vancouver, British Columbia--(Newsfile Corp. - November 12, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to the development and commercialization of a biomarker tool for monitoring depression, today announced that subject to regulatory approval, it is proposing to issue 4 Million shares @ 0.71 per share to move $3.5 Million from its balance sheet, including the full restructure of an outstanding debenture on the business. "We are pleased to announce this important agreement to restructure our balance sheet to enhance both current and prospective shareholder value and to align with our strategic goals of optimizing our capital structure," MYND Life Sciences CEO, Colin Campbell commented.» Mehr auf newsfilecorp.com

SEATTLE , Nov. 4, 2024 /PRNewswire/ -- Mynd.ai, Inc. ("Mynd" or the "Company") (NYSE American: MYND) today announced that its subsidiary, Promethean, is set to launch its most adaptable interactive flat panel display (IFPD) and software solution—the Promethean ActivPanel 10 and Promethean ActivSuite™—in the first quarter of 2025. This next-gen experience is designed with choice and simplicity in mind, allowing schools, universities, and businesses to maximize learning and collaboration in various settings.» Mehr auf prnewswire.com

School, university, and business leaders now have the flexibility to choose their experience and maximize learning and collaboration in classrooms, teaching spaces, meeting rooms, or on the go with the most adaptable, easy-to-use solution. SEATTLE , Nov. 4, 2024 /PRNewswire/ -- Promethean, a leading global tech company and brand owned by Mynd.ai, Inc. (NYSE American: MYND), has announced the most adaptable interactive flat panel display (IFPD) and software solution in Promethean's line-up—the all-new ActivPanel 10 and Promethean ActivSuite™.» Mehr auf prnewswire.com